BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MedImmune (AZN) to Present Three Influenza Abstracts at the IDWeek 2012 Meeting


10/22/2012 11:45:50 AM

GAITHERSBURG, Md., Oct. 19, 2012 /PRNewswire/ -- MedImmune, the global biologics arm of AstraZeneca, announced today it will present three influenza abstracts at IDWeek 2012: the first combined meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society, in San Diego, California, October 17-21, 2012. These abstracts expand upon the existing body of knowledge and data around flu vaccination, highlighting MedImmune's continued dedication to exceptional science, innovation, and patient health.

MedImmune flu abstracts to be presented at IDWeek 2012 include:

  • Cost-Effectiveness of Live Attenuated Influenza Vaccine Versus Inactivated Influenza Vaccine Among Children Aged 2-17 Years for Mild, Moderate and Severe Influenza Seasons. Ryan KJ, et al. Poster Session: Saturday, October 20, 2012, Time: 12:30 PM - 2:00 PM, Location: Halls F-H.
  • The Role of Nasal IgA in Children Vaccinated With Live Attenuated Influenza Vaccine. Ambrose CS, et al.Poster Session: Saturday, October 20, 2012, Time: 12:30 PM - 2:00 PM, Location: Halls F-H.
  • The Safety and Effectiveness of Self-Administration of Intranasal Live Attenuated Influenza Vaccine in Adults. Ambrose, CS, et al.Poster Session: Saturday, October 20, 2012, Time: 12:30 PM - 2:00 PM, Location: Halls F-H.

Additional information about IDWeek 2012 can be found at http://www.idweek.org/.

About MedImmune
MedImmune, the global biologics arm of AstraZeneca PLC, has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune's website at www.medimmune.com.

SOURCE MedImmune


Read at BioSpace.com


MedImmune
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->